Hollsteen
← NXP

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2016: $11.2B · 10-K 0001413447-20-000009 filed Feb 27, 2020Equity incl. NCI · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2017: $13.7B · 10-K 0001413447-20-000009 filed Feb 27, 2020Equity incl. NCI · Q1 2018: $13.9B · 10-Q 0001413447-19-000035 filed Oct 29, 2019Equity incl. NCI · Q2 2018: $13.9B · 10-Q 0001413447-19-000035 filed Oct 29, 2019Equity incl. NCI · Q3 2018: $10.8B · 10-Q 0001413447-19-000035 filed Oct 29, 2019Equity incl. NCI · Q4 2018: $10.7B · 10-K 0001413447-20-000009 filed Feb 27, 2020Equity incl. NCI · Q1 2019: $9.9B · 10-Q 0001413447-19-000035 filed Oct 29, 2019Equity incl. NCI · Q2 2019: $9.5B · 10-Q 0001413447-19-000035 filed Oct 29, 2019Equity incl. NCI · Q3 2019: $9.6B · 10-Q 0001413447-19-000035 filed Oct 29, 2019Equity incl. NCI · Q4 2019: $9.7B · 10-K 0001413447-20-000009 filed Feb 27, 2020Equity incl. NCI · Q1 2020: $9.3B · 10-Q 0001413447-20-000026 filed Apr 28, 2020Equity incl. NCI · Q2 2020: $9.1B · 10-Q 0001413447-20-000056 filed Jul 28, 2020Equity incl. NCI · Q3 2020: $9.1B · 10-Q 0001413447-20-000084 filed Oct 27, 2020Equity incl. NCI · Q4 2020: $9.2B · 10-K 0001413447-21-000011 filed Feb 25, 2021Equity incl. NCI · Q1 2021: $8.5B · 10-Q 0001413447-21-000032 filed Apr 27, 2021Equity incl. NCI · Q2 2021: $7.7B · 10-Q 0001413447-21-000062 filed Aug 3, 2021Equity incl. NCI · Q3 2021: $7.0B · 10-Q 0001413447-21-000094 filed Nov 2, 2021Equity incl. NCI · Q4 2021: $6.8B · 10-K 0001413447-22-000008 filed Feb 24, 2022Equity incl. NCI · Q1 2022: $6.8B · 10-Q 0001413447-22-000014 filed May 3, 2022Equity incl. NCI · Q2 2022: $7.2B · 10-Q 0001413447-22-000049 filed Jul 26, 2022Equity incl. NCI · Q3 2022: $7.4B · 10-Q 0001413447-22-000067 filed Nov 1, 2022Equity incl. NCI · Q4 2022: $7.7B · 10-K 0001413447-23-000006 filed Mar 1, 2023Equity incl. NCI · Q1 2023: $8.2B · 10-Q 0001413447-23-000020 filed May 2, 2023Equity incl. NCI · Q2 2023: $8.5B · 10-Q 0001413447-23-000059 filed Jul 25, 2023Equity incl. NCI · Q3 2023: $8.8B · 10-Q 0001413447-23-000107 filed Nov 7, 2023Equity incl. NCI · Q4 2023: $9.0B · 10-K 0001413447-24-000013 filed Feb 22, 2024Equity incl. NCI · Q1 2024: $9.2B · 10-Q 0001413447-24-000038 filed Apr 30, 2024Equity incl. NCI · Q2 2024: $9.3B · 10-Q 0001413447-24-000072 filed Jul 23, 2024Equity incl. NCI · Q3 2024: $9.7B · 10-Q 0001413447-24-000089 filed Nov 5, 2024Equity incl. NCI · Q4 2024: $9.5B · 10-K 0001413447-25-000019 filed Feb 20, 2025Equity incl. NCI · Q1 2025: $9.7B · 10-Q 0001413447-25-000031 filed Apr 29, 2025Equity incl. NCI · Q2 2025: $9.9B · 10-Q 0001413447-25-000106 filed Jul 24, 2025Equity incl. NCI · Q3 2025: $10.4B · 10-Q 0001413447-25-000120 filed Oct 28, 2025Equity incl. NCI · Q4 2025: $10.5B · 10-K 0001413447-26-000008 filed Feb 19, 2026Equity incl. NCI · Q1 2026: $11.3B · 10-Q 0001413447-26-000034 filed Apr 28, 20267.711.311.213.9Q1 2016Q1 2026Q2 2021
Q2 2021
7.7$B
All values (35)
PeriodValue ($B)Status
Q1 202611.3reported
Q4 202510.5reported
Q3 202510.4reported
Q2 20259.9reported
Q1 20259.7reported
Q4 20249.5reported
Q3 20249.7reported
Q2 20249.3reported
Q1 20249.2reported
Q4 20239.0reported
Q3 20238.8reported
Q2 20238.5reported
Q1 20238.2reported
Q4 20227.7reported
Q3 20227.4reported
Q2 20227.2reported
Q1 20226.8reported
Q4 20216.8reported
Q3 20217.0reported
Q2 20217.7reported
Q1 20218.5reported
Q4 20209.2reported
Q3 20209.1reported
Q2 20209.1reported
Q1 20209.3reported
Q4 20199.7reported
Q3 20199.6reported
Q2 20199.5reported
Q1 20199.9reported
Q4 201810.7reported
Q3 201810.8reported
Q2 201813.9reported
Q1 201813.9reported
Q4 201713.7reported
Q4 2016Noneerror

6 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: equity_total

More metrics for NXP
Sources & calculation
Value
$7.7B
Period
Q2 2021, ended Jul 4, 2021 · as of Jul 4, 2021 (balance as of date, not a sum)
Source
10-Q, filed Aug 3, 2021 · 0001413447-21-000062
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$7.7BAug 3, 202110-Q 0001413447-21-000062reported · confidence 1. · current